オンラインカジノウェルカムボーナス

Corporate Corporate Basic Information Message from the President Corporate Profile / Access ∟Mitsubishi Chemical Group Corporation ∟Mitsubishi Chemical Corporation ∟Mitsubishi Tanabe Pharma Corporation ∟Nippon Sanso Holdings Corporation Leadership Organization Chart Global Network Number of Subsidiaries History Corporate Brochure Evaluation by Outside Parties Approach to Corporate Activities Group Concept Charter of Corporate Behavior Value Creation Model Health and Productivity Management Management Strategy Management Policy Business Strategy ∟Specialty Materials ∟Industrial Gases ∟Health Care ∟MMA ∟Petrochemicals and Carbon Products Governance Corporate Governance ∟Corporate Governance Guidelines Risk Management Compliance Media KAITEKI Solution Center  Digital Showroom  Social Media ∟LinkedIn account  ∟X account  ∟YouTube channel  Products Innovation Innovation CTO Message --> Innovation Strategy Intellectual Property Strategy Mitsubishi Chemical Corporation R&D Main R&D Organization Award History Paper Submission Investors Investors Management Policy Message from the President --> Management Policy Disclosure Policy IR News IR News TSE Filings Basic Information Chart IR Calendar Financial Data ∟Financial Highlight ∟Historical DATA  Evaluation by Outside Parties (ESG) Other IR Information ∟FAQ on IR ∟Contact on IR ∟IR Sitemap IR library Financial Results Operating Summaries Analysts Meeting Materials Integrated Reports Securities Reports Report in Line with the Recommendations of the TCFD To Our Individual Investors The Mitsubishi Chemical Group in Numbers Stock and Bond Information ∟Stock Information ∟Dividend ∟Shareholders Meeting ∟Articles of Incorporation ∟Ratings and Bonds Sustainability Sustainability Sustainability Activities Sustainability Approach and Promotion Structure Material Issues and　Sustainability(MOS) Indices​ ESG Initiatives Environment Social Governance Sustainability Data Sustainability (MOS) Results Non-Financial Data Sheets GRI Standards Integrated report "KAITEKI Report" News News Releases Information IR News TSE Filings Contact Us 日本語 English 中文 --> --> --> --> HOME Corporate Information Evaluation by Outside Parties Evaluation by Outside Parties The following are external evaluations of initiatives taken by the MCG Group. Sustainability Management Products and Technologies Sustainability Selected as “Outstanding Enterprise in Health and Productivity Management ‐ White 500”Nippon Kenko Kaigi Recipient Mitsubishi Tanabe Pharma The "Outstanding Enterprise in Health and Productivity Management Certification System," which was established by the Ministry of Economy, Trade and Industry (METI) in 2016, is a system for recognizing companies and groups that are implementing especially strong health and productivity management. Of these companies, the White 500 program certifies large corporations that implement excellent health and productivity management in cooperation with their health insurance providers. This program, which is offered jointly by METI and Nippon Kenko Kaigi, is intended to expand the number of companies that are implementing health and productivity management. The program will certify 500 companies by 2020. Obtained Platinum Kurumin certification (system under Act on Advancement of Measures to Support Raising Next-Generation Children)Ministry of Health, Labour and Welfare Recipient Mitsubishi Tanabe Pharma Companies that have formulated an action plan to assist employees in raising their children, fulfilled the goals in such plan and met certain criteria are eligible for “Kurumin” certification. Among Kurumin-certified companies, those making efforts at a higher level are granted with “Platinum Kurumin” certification. Awarded the Gold Prize in the PRIDE INDEX for LGBT Issueswork with Pride Recipient Mitsubishi Tanabe Pharma The PRIDE INDEX, established by “work with Pride,” a private organization, is Japan’s first index that evaluates the initiatives of companies and organizations related to sexual minorities such as LGBTs. MTPC was awarded the GOLD Prize in the PRIDE INDEX 2019. Encouragement Award by Director of Chiba Labor BureauChiba Labor Bureau Recipient Chiba Sanso Center (Taiyo Nippon Sanso Group) Chiba Labor Bureau commends excellent business sites, etc. and persons of merit relating to health and safety in the form of “Commendation by the Director of Chiba Labor Bureau”; Chiba Sanso Center, Co., Ltd. of the Taiyo Nippon Sanso Group received the Encouragement Award. The 13th JCIA Responsible Care Award, RC Outstanding AwardJapan Chemical Industry Association (JCIA) Recipient Mitsubishi Chemical As part of the Responsible Care (RC) Award of Japan Chemical Industry Association, Mitsubishi Chemical Corporation’s Ibaraki Plant won the RC Outstanding Award for its activities regarding efforts to improve hazard prediction and establishment of basic operations in May 2019. Won an award in corporate HR category of HR Award 2019.Nihon no Jinjibu Recipient Mitsubishi Chemical “HR Award” of Nihon no Jinjibu is a scheme for commending innovators and industry leaders aimed at invigorating the HR domain as a whole. Good Career Company Awards 2019, Innovation AwardMinistry of Health, Labour and Welfare Recipient Mitsubishi Chemical “Good Career Company Awards” are presented by the Ministry of Health, Labour and Welfare for the purpose of commending companies recognized for their accomplishments in the efforts they have made to assist their employees in autonomous career development that serve as a model to others and widely spreading information on their principles, efforts, etc., thereby disseminating and instilling the importance of career development support. Archive Management Archive Products and Technologies “NextGen Cup Challenge” Was selected as one of the most innovative cups.NextGen Consortium Recipient Mitsubishi Chemical Paper cup using biodegradable plastic “BioPBS” “NextGen Cup Challenge,” hosted by the NextGen Consortium established by Starbucks (USA), etc., is a competition in which next-generation cups are commended. Won second grand prize in People Analytics category of Digital HR Competition 2019Digital HR Competition Recipient Mitsubishi Chemical Group Corporation Mitsubishi Chemical Data analysis for determination and action based on various data In the “Digital HR Competition” hosted by the People Analytics & HR Technology Association, a joint project by Mitsubishi Chemical Corporation and Mitsubishi Chemical Group Corporation won the second grand prize. Received the 3rd Japan Medical Research and Development Awards’ Prime Minister PrizeJapanese government Recipient Mitsubishi Tanabe Pharma Treatment agent for type 2 diabetes mellitus “Canagliflozin”(Awarded for: Molecular Identification of SGLT2 and Development of its Inhibitor) The Japan Medical Research and Development Awards, sponsored by the Japanese government, are intended to deepen the interest and understanding of the public in recognition of achievement, and increase incentives for researchers for cases that have greatly contributed to the promotion of research and development in the medical field. The Prime Minister Prize is awarded to individuals in recognition of outstanding achievement. 48th Japan Industrial Technology Awards’ Prime Minister PrizeNikkan Kogyo Shimbun, Ltd. Recipient Mitsubishi Tanabe Pharma Medication for treatment of multiple sclerosis “Fingolimod”(Awarded for: Fingolimod hydrochloride, medication for treatment of multiple sclerosis) Won the “Prime Minister Prize,” the top prize among the “Japan Industrial Technology Awards,” which are granted for R&D and practical application technologies that have made outstanding achievements for industrial/social progress. Winner of the 51st Ichimura Prize in Industry for Outstanding AchievementIchimura Foundation for New Technology Recipient Mitsubishi Tanabe Pharma Treatment agent for type 2 diabetes mellitus “Canagliflozin”(Awarded for: Canagliflozin, a treatment agent for type 2 diabetes mellitus derived from reverse thinking) The Ichimura Prize in Industry is presented to technology developers or groups who have contributed to developments and achievements in the industrial field based on their creation of outstanding made-in-Japan technology, and Outstanding Achievement is the highest ranking award. The Commendation for Science and Technology by the Minister of Education, Culture, Sports, Science and Technology, 2019Award for Science and Technology (Development Category)Ministry of Education, Culture, Sports, Science and Technology Recipient Mitsubishi Tanabe Pharma Treatment agent for type 2 diabetes “Teneligliptin”(Awarded for: invention and development of new DPP-4 inhibitor made entirely in Japan) “The Commendation for Science and Technology by the Minister of Education, Culture, Sports, Science and Technology” is an award aimed at giving greater motivation to individuals engaged in science and technology and contributing toward the enhancement of Japan’s science and technology standards. Received the Good Design Award 2019 (Category: Medical equipment and facilities)Japan Institute of Design Promotion Recipient Mitsubishi Tanabe Pharma Simponi® Subcutaneous Injection 50 mg Autoinjector The Good Design Award was established in 1957 and is Japan’s only comprehensive design evaluation and recommendation structure. The global design award is held every year for the purpose of improving the quality of life and leveraging design to solve social issues. The award-winning “G Mark” symbol is widely recognized as a symbol of excellence in design. Breakthrough Award, Division of Medicinal Chemistry, The Pharmaceutical Society of JapanDivision of Medicinal Chemistry, The Pharmaceutical Society of Japan Recipient Mitsubishi Tanabe Pharma Medication for treatment of secondary hyperparathyroidism “Evocalcet”(Awarded for: Discovery of evocalcet, medication for treatment of secondary hyperparathyroidism) “Breakthrough Award, Division of Medicinal Chemistry, Pharmaceutical Society of Japan” is granted to researchers who have made research accomplishments including breakthroughs that contribute to the progress of drug discovery for their unique research accomplishments related to drugs or bioactive compounds with new chemical structures and unique research accomplishments that contribute to drug discovery research through new technologies, methods, etc. Received the Award for Hangover Antidote at the 32nd “Hit Product Award/Topic Product Award (in the Pharmaceutical/Designated Quasi-drug Category)”Drugmagazine Co., Ltd / and Yachiyokai Recipient Mitsubishi Tanabe Pharma the over-the-counter drug “Urusoukon” In June 2020, the over-the-counter drug “Urusoukon” received the Award for Hangover Antidote at the 32nd Hit Product Award/Topic Product Award in the Pharmaceuticals/Designated Quasi-drug Category (sponsored by Drugmagazine Co., Ltd. and Yachiyokai). Since the 29th Hit Product Award/Topic Product Award, this marks the fourth consecutive year that Tanabe Mitsubishi Pharma has won this award. Supplier Excellence AwardEPISTAR Corporation Recipient Taiyo Nippon Sanso Taiwan Stable supply of high-quality special gas products for many years Received “Supplier Excellence Award,” granted to outstanding partner companies from among approx. 300 suppliers invited to the Strategic Partners Technology Forum held annually by EPISTAR Corporation. Best Supplier AwardIBIDEN Philippines Recipient INGASCO Inc. (Taiyo Nippon Sanso Group) Quality, stable supply, productivity and cost advantage of on-site in-plant nitrogen gas supply Ingasco, Inc. received an award from IBIDEN Philippines, Inc. in recognition of its performance in meeting customer expectations for quality and stable supply. Archive Related Information Evaluation by Outside Parties (ESG Index) Corporate Information Corporate Information Corporate Information Basic Information Message from the President Corporate Profile / Access ∟Mitsubishi Chemical Group Corporation ∟Mitsubishi Chemical Corporation ∟Mitsubishi Tanabe Pharma Corporation ∟Nippon Sanso Holdings Corporation Leadership Organization Chart Global Network Number of Subsidiaries History Corporate Brochure Evaluation by Outside Parties Approach to Corporate Activities Group Concept Charter of Corporate Behavior Value Creation Model Health and Productivity Management Management Strategy Management Policy Business Strategy ∟Specialty Materials ∟Industrial Gases ∟Health Care ∟MMA ∟Petrochemicals and Carbon Products Governance Corporate Governance ∟Corporate Governance Guidelines Risk Management Compliance Media KAITEKI Solution Center Digital Showroom Social Media ∟LinkedIn account  ∟X account  ∟YouTube channel  Business・Products Business・Products Innovation Innovation Innovation CTO Message --> Innovation Strategy Intellectual Property Strategy Mitsubishi Chemical Corporation R&D Main R&D Organization Award History Paper Submission Investor Relations Investor Relations Investor Relations Management Policy Message from the President --> Message from the CFO --> Outside Directors’ Discussion Meeting --> Management Policy Disclosure Policy IR News IR News TSE Filings Basic Information Chart IR Calendar Financial Data Evaluation by Outside Parties (ESG) Other IR Information ∟FAQ on IR ∟Contact on IR ∟IR Sitemap IR library Financial Results Operating Summaries Analysts Meeting Materials Integrated Reports Securities Reports Report in Line with the Recommendations of the TCFD To Our Individual Investors The Mitsubishi Chemical Group in Numbers Stock and Bond Information Sustainability Sustainability Sustainability Sustainability Activities Sustainability approach and promotion structure Material Issues and Sustainability(MOS) Indices ESG Initiatives Environment Society Governance Sustainability Data Sustainability (MOS) results Non-Financial Data Sheets GRI Standards KAITEKI Solution Center News Releases Information Digital Showroom Contact Us FAQ The Mitsubishi Chemical Group Official Accounts Sitemap Terms of Use Privacy Policy Social Media Terms of Use Copyright © Mitsubishi Chemical Group Corporation.